Stephanie Wheeler Archives

Arati Prabhakar during the roundtable discussion.

The White House Chief Science and Technology Advisor Arati Prabhakar, MS, PhD, visited Chapel Hill to discuss the fight against cancer at the UNC Lineberger Comprehensive Cancer Center.

Patient in a hospital bed holds their caregiver's hand

A study led by Katherine Reeder-Hayes, MD, MBA, MS, found that Black patients and patients living in certain regions experience greater delays.

The UNC Lineberger annual scientific retreat featured faculty talks covering a range of basic, clinical/translational and population science research, as well as a poster session.

Person in a hospital bed with an IV drip

Researchers developed three different computer models to predict how a hypothetical set of patients with specific types of metastatic breast cancer would respond to different sequences and types of chemotherapy.

Physician meets with patient in a clinic setting

UNC Lineberger’s Office of Community Outreach and Engagement has begun a major, new data-driven initiative that will comprehensively describe the cancer burden in North Carolina.

Led by Noel Brewer, PhD, UNC-Chapel Hill researchers are launching a new project to give providers the support necessary to improve HPV vaccine communication.

Stephanie Wheeler, PhD, MPH, and Justin Trogdon, PhD, are co-authors of a study building upon previous metastatic breast cancer research on medical and productivity costs.

Tag: Stephanie Wheeler

UNC Lineberger hosts White House Chief Science & Technology Advisor

ABC 11: White House Advisor Visits UNC Lineberger

Race and geography linked to different risks of breast cancer treatment delays

Scientific retreat brings together cancer center community, offers insights across research fields

Specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

Expanded community data project will improve understanding of cancer

UNC awarded $11.7 million to help providers improve HPV vaccine communication, uptake among adolescents

Cancer Network: The Costs Associated With Metastatic Breast Cancer Estimated to Rise By 2030

Study estimates costs of treating and living with metastatic breast cancer will more than double between 2015 and 2030, due to increase in cases among younger women

Journal of Clinical Pathways: Patterns and Predictors of Oral Anticancer Agent Use for Metastatic RCC